• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A newly synthesized compound attenuates aging-related renal fibrosis and mitochondrial dysfunction in aging model mice

Research Project

Project/Area Number 18K17917
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 59040:Nutrition science and health science-related
Research InstitutionNational Agriculture and Food Research Organization

Principal Investigator

Nanto-Hara Fumika  国立研究開発法人農業・食品産業技術総合研究機構, 畜産研究部門, 研究員 (00781684)

Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2019: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2018: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Keywordsミトコンドリア / 老化 / 腎障害 / α‐Klotho遺伝子 / 腎臓 / 代謝
Outline of Final Research Achievements

Aging is a risk factor for many of the diseases and is associated with a decline in mitochondrial function. Recently, we reported that a newly synthesized compound A, increases cellular ATP level and survival of fibroblasts from patients with mitochondrial disease. In this study, we applied this compound to aging mice model. Administration of compound A to the mice model significantly prolonged life-span and attenuated the aging-rerated fibrosis of kidney. In in vitro studies, compound A reduced proton leak in isolated mitochondria from kidney of mice, which suggested that compound A maintain membrane potential to improve the mitochondrial respiration. Metabolome analysis revealed increased citric acid, iso-citric acid and spermidine levels in compound A treated mice, suggesting that these metabolites may candidate as an anti-aging biomarker. These results suggest that compound A could be a novel therapeutic drug for preventing aging associated with mitochondrial dysfunction.

Academic Significance and Societal Importance of the Research Achievements

本研究では、新規ミトコンドリア機能改善薬により、生体のミトコンドリア機能を維持・適正化することで老化を予防し、その進展を阻止できるという新たな老化抑制法の可能性を、老化マウスを用いた実験で明らかにした。本成果は、今後迎える超高齢化社会において、健康寿命の延伸やQuality of life向上に寄与することが期待される。

Report

(2 results)
  • 2020 Final Research Report ( PDF )
  • 2018 Research-status Report
  • Research Products

    (2 results)

All 2018

All Presentation (2 results)

  • [Presentation] グアニル酸シクラーゼC受容体作動薬リナクロチドは腎不全に伴う腸内環境悪性化を改善し腎線維化を抑制する2018

    • Author(s)
      原文香、福田真嗣、金光祥臣、何欣蓉、菊地晃一、岩崎智行、三枝大輔、三島英換、鈴木健弘、松橋徹郎、及川義嗣、鈴木千登世、富岡佳久、曽我朋義、伊藤貞嘉、阿部高明
    • Organizer
      第2回日本Uremic Toxin研究会学術集会
    • Related Report
      2018 Research-status Report
  • [Presentation] グアニル酸シクラーゼC受容体作動薬リナクロチドは腎不全に伴う腸内環境悪性化を改善し腎線維化を抑制する2018

    • Author(s)
      原文香、福田真嗣、金光祥臣、何欣蓉、菊地晃一、岩崎智行、三枝大輔、三島英換、鈴木健弘、松橋徹郎、及川義嗣、鈴木千登世、富岡佳久、曽我朋義、伊藤貞嘉、阿部高明
    • Organizer
      第61回日本腎臓学会学術総会
    • Related Report
      2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi